Literature DB >> 33381424

In vivo effects of nitrosyl hydrogen on cardiac function and sarcoplasmic reticulum calcium pump (SERCA2a) in rats with heart failure after myocardial infarction.

Yanqing Guo1, Jiyao Xu1, Yongzhi Deng2, Li Wu1, Jingping Wang1, Jian An1.   

Abstract

BACKGROUND: Abnormal Ca2+ circulation in cardiomyocytes is an important cause of decreased myocardial contractility in failing hearts. Nitroxyl hydrogen (HNO) can oxidize Ca2+ cycle-related proteins, alter their biological functions, promote Ca2+ recovery as well as release, and enhance myocardial contractility. In this study, we aim to observe the effect of nitrosyl hydrogen (HNO) on the cardiac function of rats with heart failure and elucidate the underlying mechanism.
METHODS: Twenty six male Wistar rats were randomly divided into heart failure group (HF group), Angeli's salt treatment group (HF + AS group) and sham operation group (Sham group). The HF + AS group rats were treated with HNO donor Angeli's salt by intraperitoneal injection of 1 mg/kg/d, and the rats in the HF group and the Sham group were given the same amount of normal saline. Cardiac function was measured by echocardiography before and after treatment. NT-proBNP was measured by enzyme immunoassay (ELISA) kit after treatment. Western blot were used to measure the expression of sarcoplasmic reticulum Ca2+-ATPase (SERCA) in protein levels in rats. The activities of SERCA2a were detected by the biochemical kit finally.
RESULTS: We found that Nitrosyl hydrogen could significantly increase LVEF, +dp/dt, -dp/dt (P<0.05), significantly decrease NT-ProBNP and LVEDP (P<0.01), and significantly enhance the activities of SERCA2a protein (P<0.05).
CONCLUSIONS: These findings suggest that Nitrosyl hydrogen could improve the cardiac function possibly by increasing protein activities of SERCA2a in rats. 2020 Cardiovascular Diagnosis and Therapy. All rights reserved.

Entities:  

Keywords:  Nitroxyl; heart failure; hemodynamic; sarcoplasmic reticulum calcium pump

Year:  2020        PMID: 33381424      PMCID: PMC7758752          DOI: 10.21037/cdt-20-201

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN: 2223-3652


  30 in total

1.  The nitroxyl anion (HNO) is a potent dilator of rat coronary vasculature.

Authors:  Joanne L Favaloro; Barbara K Kemp-Harper
Journal:  Cardiovasc Res       Date:  2006-11-18       Impact factor: 10.787

2.  Improved systolic function of rat cardiocytes during heart failure by overexpression of SERCA2a.

Authors:  H-B Gong; L Wang; Q Lv; J Wang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2016-04       Impact factor: 3.507

Review 3.  HNO signaling mechanisms.

Authors:  Jon M Fukuto; Samantha J Carrington
Journal:  Antioxid Redox Signal       Date:  2011-03-02       Impact factor: 8.401

Review 4.  Therapeutic potential of vasopressin-receptor antagonists in heart failure.

Authors:  Yasukatsu Izumi; Katsuyuki Miura; Hiroshi Iwao
Journal:  J Pharmacol Sci       Date:  2014-01-07       Impact factor: 3.337

5.  Nitroxyl (HNO) reduces endothelial and monocyte activation and promotes M2 macrophage polarization.

Authors:  Karen L Andrews; Amanda K Sampson; Jennifer C Irvine; Waled A Shihata; Danielle L Michell; Natalie G Lumsden; Chloe Lim; Olivier Huet; Grant R Drummond; Barbara K Kemp-Harper; Jaye P F Chin-Dusting
Journal:  Clin Sci (Lond)       Date:  2016-05-26       Impact factor: 6.124

Review 6.  Playing with cardiac "redox switches": the "HNO way" to modulate cardiac function.

Authors:  Carlo G Tocchetti; Brian A Stanley; Christopher I Murray; Vidhya Sivakumaran; Sonia Donzelli; Daniele Mancardi; Pasquale Pagliaro; Wei Dong Gao; Jennifer van Eyk; David A Kass; David A Wink; Nazareno Paolocci
Journal:  Antioxid Redox Signal       Date:  2011-03-03       Impact factor: 8.401

Review 7.  The chemistry of nitroxyl-releasing compounds.

Authors:  Jenna F DuMond; S Bruce King
Journal:  Antioxid Redox Signal       Date:  2011-03-02       Impact factor: 8.401

8.  Astragaloside IV enhances cardioprotection of remote ischemic conditioning after acute myocardial infarction in rats.

Authors:  Songyi Cheng; Peng Yu; Li Yang; Haibo Shi; Anxia He; Hanyu Chen; Jie Han; Liang Xie; Jiandong Chen; Xiaohu Chen
Journal:  Am J Transl Res       Date:  2016-11-15       Impact factor: 4.060

9.  Cardio-protecteffect of qiliqiangxin capsule on left ventricular remodeling, dysfunction and apoptosis in heart failure rats after chronic myocardial infarction.

Authors:  Tuo Liang; Yuhui Zhang; Shijie Yin; Tianyi Gan; Tao An; Rongcheng Zhang; Yunhong Wang; Yan Huang; Qiong Zhou; Jian Zhang
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

Review 10.  Examining nitroxyl in biological systems.

Authors:  Jon M Fukuto; Matthew I Jackson; Nina Kaludercic; Nazareno Paolocci
Journal:  Methods Enzymol       Date:  2008       Impact factor: 1.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.